25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BioForce Nanosciences Holdings Inc
Buy, Hold or Sell?

Let's analyze BioForce Nanosciences Holdings Inc together

I guess you are interested in BioForce Nanosciences Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioForce Nanosciences Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioForce Nanosciences Holdings Inc

I send you an email if I find something interesting about BioForce Nanosciences Holdings Inc.

Quick analysis of BioForce Nanosciences Holdings Inc (30 sec.)










What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.06
Expected worth in 1 year
$-0.07
How sure are you?
19.4%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-1.1%

For what price can you sell your share?

Current Price per Share
$1.05
Expected price per share
$0.55 - $2.01
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of BioForce Nanosciences Holdings Inc (5 min.)




Live pricePrice per Share (EOD)

$1.05

Intrinsic Value Per Share

$0.03 - $0.03

Total Value Per Share

$-0.04 - $-0.03

2. Growth of BioForce Nanosciences Holdings Inc (5 min.)




Is BioForce Nanosciences Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.8m-$1.2m-$441.8k-25.5%

How much money is BioForce Nanosciences Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$114k-$58.7k-$55.3k-48.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of BioForce Nanosciences Holdings Inc (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#479 / 493

Most Revenue
#492 / 493

Most Profit
#364 / 493

Most Efficient
#360 / 493
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc? (5 min.)

Welcome investor! BioForce Nanosciences Holdings Inc's management wants to use your money to grow the business. In return you get a share of BioForce Nanosciences Holdings Inc.

What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc?

First you should know what it really means to hold a share of BioForce Nanosciences Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of BioForce Nanosciences Holdings Inc is $1.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioForce Nanosciences Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioForce Nanosciences Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.06. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioForce Nanosciences Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.4%0.00-0.4%0.00-0.4%-0.27-26.0%-0.15-14.5%
Usd Book Value Change Per Share0.000.0%0.00-0.3%0.00-0.4%0.00-0.3%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.00-0.3%0.00-0.4%0.00-0.3%0.00-0.2%
Usd Price Per Share1.70-1.75-2.27-1.41-0.98-
Price to Earnings Ratio-108.74--112.40--139.26--162.48--253.22-
Price-to-Total Gains Ratio-454.49--557.20--251.52--143.37-
Price to Book Ratio-27.35--29.53--53.79-154.68-600.54-
Price-to-Total Gains Ratio-454.49--557.20--251.52--143.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.05
Number of shares952
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (952 shares)-2.78-3.01
Gains per Year (952 shares)-11.12-12.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-11-210-12-22
20-22-320-24-34
30-33-430-36-46
40-44-540-48-58
50-56-650-60-70
60-67-760-72-82
70-78-870-84-94
80-89-980-96-106
90-100-1090-109-118
100-111-1200-121-130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.034.00.05.6%2.045.00.04.3%
Book Value Change Per Share0.03.01.00.0%0.011.01.00.0%2.017.01.010.0%7.027.02.019.4%9.036.02.019.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%4.00.043.08.5%
Total Gains per Share0.03.01.00.0%0.011.01.00.0%2.017.01.010.0%7.027.02.019.4%9.036.02.019.1%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of BioForce Nanosciences Holdings Inc

About BioForce Nanosciences Holdings Inc

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

Fundamental data was last updated by Penke on 2024-07-17 17:50:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of BioForce Nanosciences Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BioForce Nanosciences Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.7%+5.7%
5Y-5.7%10Y-69.6%+63.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-3.2%-3.2%
YOY-2.7%-2.7%
5Y-5.7%3.3%-9.0%
10Y-69.6%3.6%-73.2%
1.1.2. Return on Assets

Shows how efficient BioForce Nanosciences Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • -17,932.6% Return on Assets means that BioForce Nanosciences Holdings Inc generated $-179.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is -17,932.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17,461.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17,932.6%TTM-17,461.7%-470.9%
TTM-17,461.7%YOY-4,592.1%-12,869.6%
TTM-17,461.7%5Y-20,022.5%+2,560.8%
5Y-20,022.5%10Y-11,138.9%-8,883.5%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-17,932.6%1.2%-17,933.8%
TTM-17,461.7%1.2%-17,462.9%
YOY-4,592.1%1.1%-4,593.2%
5Y-20,022.5%1.2%-20,023.7%
10Y-11,138.9%1.3%-11,140.2%
1.1.3. Return on Equity

Shows how efficient BioForce Nanosciences Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • 0.0% Return on Equity means BioForce Nanosciences Holdings Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-108,414.5%+108,414.5%
5Y-108,414.5%10Y-60,258.0%-48,156.5%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.4%-2.4%
TTM-2.4%-2.4%
YOY-2.2%-2.2%
5Y-108,414.5%2.4%-108,416.9%
10Y-60,258.0%2.6%-60,260.6%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of BioForce Nanosciences Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BioForce Nanosciences Holdings Inc is operating .

  • Measures how much profit BioForce Nanosciences Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.7%+5.7%
5Y-5.7%10Y-64.6%+59.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-5.3%
TTM-2.7%-2.7%
YOY-4.0%-4.0%
5Y-5.7%4.6%-10.3%
10Y-64.6%4.9%-69.5%
1.2.2. Operating Ratio

Measures how efficient BioForce Nanosciences Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.119-0.119
5Y0.11910Y0.980-0.861
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.513-1.513
TTM-1.459-1.459
YOY-1.347-1.347
5Y0.1191.314-1.195
10Y0.9801.197-0.217
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of BioForce Nanosciences Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.000. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.000TTM0.0000.000
TTM0.000YOY0.002-0.002
TTM0.0005Y1.397-1.396
5Y1.39710Y11.568-10.172
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0001.572-1.572
TTM0.0001.561-1.561
YOY0.0021.609-1.607
5Y1.3971.637-0.240
10Y11.5681.614+9.954
1.3.2. Quick Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.000. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.000TTM0.000+0.000
TTM0.000YOY0.002-0.002
TTM0.0005Y1.365-1.365
5Y1.36510Y10.015-8.650
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0000.557-0.557
TTM0.0000.567-0.567
YOY0.0020.620-0.618
5Y1.3650.697+0.668
10Y10.0150.732+9.283
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of BioForce Nanosciences Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BioForce Nanosciences Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BioForce Nanosciences Holdings Inc to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 2,852.46 means that BioForce Nanosciences Holdings Inc assets are financed with 285,245.8% credit (debt) and the remaining percentage (100% - 285,245.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 2,852.458. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2,656.281. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2,852.458TTM2,656.281+196.177
TTM2,656.281YOY1,439.164+1,217.117
TTM2,656.2815Y832.067+1,824.213
5Y832.06710Y462.323+369.745
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ2,852.4580.472+2,851.986
TTM2,656.2810.484+2,655.797
YOY1,439.1640.481+1,438.683
5Y832.0670.483+831.584
10Y462.3230.488+461.835
1.4.2. Debt to Equity Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.325-0.325
5Y0.32510Y0.302+0.023
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.900-0.900
TTM-0.952-0.952
YOY-0.938-0.938
5Y0.3250.983-0.658
10Y0.3021.035-0.733
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of BioForce Nanosciences Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings BioForce Nanosciences Holdings Inc generates.

  • Above 15 is considered overpriced but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A PE ratio of -108.74 means the investor is paying $-108.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -67.161. Based on the earnings, the company is expensive. -2
  • The MRQ is -108.736. Based on the earnings, the company is expensive. -2
  • The TTM is -112.401. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-67.161MRQ-108.736+41.576
MRQ-108.736TTM-112.401+3.665
TTM-112.401YOY-139.260+26.859
TTM-112.4015Y-162.479+50.078
5Y-162.47910Y-253.217+90.737
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-67.16113.507-80.668
MRQ-108.73613.195-121.931
TTM-112.40113.166-125.567
YOY-139.26013.253-152.513
5Y-162.47916.819-179.298
10Y-253.21719.277-272.494
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -1,084.370. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1,755.647. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1,692.219. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1,084.370MRQ-1,755.647+671.277
MRQ-1,755.647TTM-1,692.219-63.428
TTM-1,692.219YOY-1,362.343-329.876
TTM-1,692.2195Y-1,051.011-641.208
5Y-1,051.01110Y-773.578-277.434
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-1,084.3704.221-1,088.591
MRQ-1,755.6474.061-1,759.708
TTM-1,692.2192.916-1,695.135
YOY-1,362.3430.357-1,362.700
5Y-1,051.0111.230-1,052.241
10Y-773.5781.298-774.876
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BioForce Nanosciences Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of -27.35 means the investor is paying $-27.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -16.895. Based on the equity, the company is expensive. -2
  • The MRQ is -27.353. Based on the equity, the company is expensive. -2
  • The TTM is -29.533. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.895MRQ-27.353+10.459
MRQ-27.353TTM-29.533+2.180
TTM-29.533YOY-53.792+24.258
TTM-29.5335Y154.684-184.218
5Y154.68410Y600.543-445.859
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-16.8951.322-18.217
MRQ-27.3531.462-28.815
TTM-29.5331.445-30.978
YOY-53.7921.567-55.359
5Y154.6841.888+152.796
10Y600.5432.388+598.155
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioForce Nanosciences Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0030%-0.0040%-0.0030%-0.0020%
Book Value Per Share---0.062-0.059-5%-0.044-29%-0.028-55%-0.015-75%
Current Ratio--0.0000.000-7%0.002-86%1.397-100%11.568-100%
Debt To Asset Ratio--2852.4582656.281+7%1439.164+98%832.067+243%462.323+517%
Debt To Equity Ratio----0%-0%0.325-100%0.302-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.0040%-0.004+6%-0.273+6893%-0.152+3787%
Free Cash Flow Per Share--0.0000.000+8%0.000+106%-0.001+110%0.000+50%
Free Cash Flow To Equity Per Share--0.0000.000-50%0.000+5327%0.000+3497%0.000+619%
Gross Profit Margin--1.0001.0000%1.0000%1.017-2%1.010-1%
Intrinsic Value_10Y_max--0.032--------
Intrinsic Value_10Y_min--0.026--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.005--------
Intrinsic Value_5Y_min--0.004--------
Market Cap30735390.000-62%49762060.00051298829.500-3%66520165.500-25%41243966.200+21%31403981.545+58%
Net Profit Margin----0%-0%-0.0570%-0.6960%
Operating Margin----0%-0%-0.0570%-0.6460%
Operating Ratio----0%-0%0.119-100%0.980-100%
Pb Ratio-16.895+38%-27.353-29.533+8%-53.792+97%154.684-118%600.543-105%
Pe Ratio-67.161+38%-108.736-112.401+3%-139.260+28%-162.479+49%-253.217+133%
Price Per Share1.050-62%1.7001.753-3%2.273-25%1.409+21%0.983+73%
Price To Free Cash Flow Ratio-1084.370+38%-1755.647-1692.219-4%-1362.343-22%-1051.011-40%-773.578-56%
Quick Ratio--0.0000.000+21%0.002-86%1.365-100%10.015-100%
Return On Assets---179.326-174.617-3%-45.921-74%-200.225+12%-111.389-38%
Return On Equity----0%-0%-1084.1450%-602.5800%
Total Gains Per Share----0.0030%-0.0040%-0.0030%-0.0020%
Usd Book Value---1819230.000-1733623.250-5%-1291789.000-29%-820151.900-55%-447895.722-75%
Usd Book Value Change Per Share----0.0030%-0.0040%-0.0030%-0.0020%
Usd Book Value Per Share---0.062-0.059-5%-0.044-29%-0.028-55%-0.015-75%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.0040%-0.004+6%-0.273+6893%-0.152+3787%
Usd Free Cash Flow---7086.000-7683.500+8%-14625.500+106%-14854.650+110%-10183.028+44%
Usd Free Cash Flow Per Share--0.0000.000+8%0.000+106%-0.001+110%0.000+50%
Usd Free Cash Flow To Equity Per Share--0.0000.000-50%0.000+5327%0.000+3497%0.000+619%
Usd Market Cap30735390.000-62%49762060.00051298829.500-3%66520165.500-25%41243966.200+21%31403981.545+58%
Usd Price Per Share1.050-62%1.7001.753-3%2.273-25%1.409+21%0.983+73%
Usd Profit---114410.000-114089.5000%-58729.750-49%-7988394.050+6882%-4441474.500+3782%
Usd Revenue----0%-0%-292.5000%855.806-100%
Usd Total Gains Per Share----0.0030%-0.0040%-0.0030%-0.0020%
 EOD+1 -6MRQTTM+6 -16YOY+9 -135Y+16 -910Y+15 -11

3.2. Fundamental Score

Let's check the fundamental score of BioForce Nanosciences Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-67.161
Price to Book Ratio (EOD)Between0-1-16.895
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than12,852.458
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-179.326
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of BioForce Nanosciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.050
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1
Total Liabilities1,820
Total Stockholder Equity-1,819
 As reported
Total Liabilities 1,820
Total Stockholder Equity+ -1,819
Total Assets = 1

Assets

Total Assets1
Total Current Assets1
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1
Total Current Assets  (as reported)1
Total Current Assets  (calculated)1
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,820
Long-term Liabilities0
Total Stockholder Equity-1,819
Total Current Liabilities
Short-term Debt 221
Accounts payable 3
Other Current Liabilities 1,817
Total Current Liabilities  (as reported)1,820
Total Current Liabilities  (calculated)2,041
+/- 221
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock29
Retained Earnings -160,630
Other Stockholders Equity 158,781
Total Stockholder Equity (as reported)-1,819
Total Stockholder Equity (calculated)-1,819
+/-0
Other
Capital Stock29
Cash and Short Term Investments 1
Common Stock Shares Outstanding 29,272
Current Deferred Revenue-221
Liabilities and Stockholders Equity 1
Net Debt 220
Net Invested Capital -1,950
Net Working Capital -1,950
Short Long Term Debt Total 221



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-302006-03-312005-09-302005-06-30
> Total Assets 
0
0
6,500
5,936
5,390
5,061
3,529
3,192
3,091
2,579
2,306
2,197
21
21
20
20
19
18
18
18
16
16
15
15
14
13
12
21
21
24
29
35
41
47
53
59
51
43
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
111111191111272732404043515953474135292421211213141515161618181819202021212,1972,3062,5793,0913,1923,5295,0615,3905,9366,50000
   > Total Current Assets 
0
0
5,433
4,864
4,247
3,874
2,119
1,790
1,775
1,256
1,058
1,127
21
21
20
20
19
18
18
18
16
16
15
15
14
13
12
21
21
24
29
35
41
47
53
59
51
43
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
111111191111272732404043515953474135292421211213141515161618181819202021211,1271,0581,2561,7751,7902,1193,8744,2474,8645,43300
       Cash And Cash Equivalents 
0
0
5,356
4,467
3,631
2,603
762
552
269
58
56
12
21
21
20
20
19
0
18
18
16
16
15
14
14
13
12
14
14
24
24
29
35
41
47
53
47
40
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
11111119111127273240404047534741352924241414121314141516161818019202021211256582695527622,6033,6314,4675,35600
       Net Receivables 
0
0
16
14
9
22
272
6
314
207
128
269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
0
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000666660550000000000000002691282073146272229141600
       Other Current Assets 
0
0
6
66
48
55
116
102
146
91
55
77
21
0
0
20
0
18
0
18
0
0
0
15
14
13
0
2
2
0
0
0
0
0
0
6
5
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000356000000220131415000180180200021775591146102116554866600
   > Long-term Assets 
0
0
1,068
1,072
1,142
1,187
1,410
1,403
1,316
1,322
1,248
1,070
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000001,0701,2481,3221,3161,4031,4101,1871,1421,0721,06800
       Property Plant Equipment 
0
0
555
524
549
538
695
638
584
546
465
375
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000037546554658463869553854952455500
       Intangible Assets 
0
0
513
548
593
649
715
764
732
777
783
675
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000067578377773276471564959354851300
> Total Liabilities 
41
43
45
603
621
1,119
1,009
1,051
858
917
1,331
1,703
0
0
0
1
1
1
1
1
1
1
1
-1
1
1
1
13
13
8
5
5
7
5
5
12
44
162
277
400
537
655
769
873
1,005
1,119
1,233
1,348
1,478
1,592
1,706
1,820
1,820
1,8201,8201,7061,5921,4781,3481,2331,1191,00587376965553740027716244125575581313111-1111111110001,7031,3319178581,0511,0091,119621603454341
   > Total Current Liabilities 
41
43
45
171
226
840
798
891
703
774
1,193
1,588
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
13
13
8
5
5
7
5
5
12
44
162
277
400
537
655
769
873
1,005
1,119
1,233
1,348
1,478
1,592
1,706
1,820
1,820
1,8201,8201,7061,5921,4781,3481,2331,1191,005873769655537400277162441255755813131111111111110001,5881,193774703891798840226171454341
       Short-term Debt 
0
0
0
0
26
132
238
109
89
73
296
719
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
34
47
56
0
0
0
0
0
0
157
165
174
197
206
214
0
221
22102142061971741651570000005647340000000001111000000000007192967389109238132260000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
34
47
56
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000564734000000000111100000000000000000000000
       Accounts payable 
4
3
41
163
200
506
247
318
305
418
543
506
0
0
0
1
0
1
1
1
1
1
1
1
1
1
1
13
13
8
5
5
7
5
5
10
1
0
0
5
12
1
0
6
0
0
1
0
2
1
1
3
3
3311201006011250011055755813131111111111010005065434183053182475062001634134
       Other Current Liabilities 
38
39
4
8
0
193
257
422
255
246
311
331
0
0
0
0
1
-1
0
0
0
0
0
0
-1
-1
0
0
13
8
0
5
7
5
5
1
10
115
221
395
525
654
768
867
1,005
1,119
1,232
1,348
1,476
1,591
1,704
0
1,817
1,81701,7041,5911,4761,3481,2321,1191,0058677686545253952211151015575081300-1-1000000-1100003313112462554222571930843938
   > Long-term Liabilities 
0
0
444
433
395
279
211
159
155
144
138
115
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
00002010000000000000000000000-10000000000011513814415515921127939543344400
> Total Stockholder Equity
-41
-43
-45
5,333
4,769
3,942
2,520
2,142
2,233
1,661
975
495
21
20
20
19
19
36
17
17
16
15
15
-21
-63
-423
12
8
8
16
24
30
34
42
48
47
7
-119
-237
-360
-505
-627
-741
-862
-994
-1,110
-1,233
-1,347
-1,477
-1,591
-1,705
-1,819
-1,819
-1,819-1,819-1,705-1,591-1,477-1,347-1,233-1,110-994-862-741-627-505-360-237-1197474842343024168812-423-63-2115151617173619192020214959751,6612,2332,1422,5203,9424,7695,333-45-43-41
   Common Stock
2
2
4
24
24
24
24
24
25
25
25
25
0
0
0
0
0
0
0
0
0
36
36
76
76
76
76
76
76
76
76
76
76
76
76
15
15
15
15
29
29
29
29
29
29
29
29
29
29
29
29
0
29
290292929292929292929292929151515157676767676767676767676763636000000000252525252424242424422
   Retained Earnings 
-376
-378
-380
0
-8,600
-9,907
-11,915
-13,548
-14,135
-14,891
-15,815
-16,506
21
20
20
0
0
0
0
0
0
-21
-21
-21
-63
-423
-447
-647
-647
-700
-707
-715
-728
-735
-742
-762
-158,803
-158,930
-159,048
-159,170
-159,315
-159,438
-159,552
-159,672
-159,805
-159,920
-160,043
-160,158
-160,288
-160,402
-160,515
-160,630
-160,630
-160,630-160,630-160,515-160,402-160,288-160,158-160,043-159,920-159,805-159,672-159,552-159,438-159,315-159,170-159,048-158,930-158,803-762-742-735-728-715-707-700-647-647-447-423-63-21-21-21000000202021-16,506-15,815-14,891-14,135-13,548-11,915-9,907-8,6000-380-378-376
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
158,781
0
158,781
158,781
0
0
0
0
0
0
000000158,781158,7810158,7810000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
332
333
332
5,887
13,966
14,494
14,668
16,492
17,231
16,531
16,784
16,999
0
0
0
19
19
36
17
17
16
0
0
-76
0
0
383
0
579
640
654
669
686
701
714
794
158,793
158,793
158,793
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
0
158,781
158,7810158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,793158,793158,793794714701686669654640579038300-760016171736191900016,99916,78416,53117,23116,49214,66814,49413,9665,887332333332



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-472
Operating Income-472-472
 
Operating Expense (+$)
Research Development0
Selling General Administrative472
Selling And Marketing Expenses0
Operating Expense472472
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-472
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-472-472
EBIT - interestExpense = -944
-944
-472
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-944-472
Earnings Before Interest and Taxes (EBITDA)-472
 
After tax Income (+$)
Income Before Tax-472
Tax Provision-0
Net Income From Continuing Ops-472-472
Net Income-472
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses472
Total Other Income/Expenses Net00
 

Technical Analysis of BioForce Nanosciences Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioForce Nanosciences Holdings Inc. The general trend of BioForce Nanosciences Holdings Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioForce Nanosciences Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioForce Nanosciences Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.88 < 2 < 2.01.

The bearish price targets are: 0.88 > 0.87 > 0.55.

Tweet this
BioForce Nanosciences Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioForce Nanosciences Holdings Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioForce Nanosciences Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioForce Nanosciences Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioForce Nanosciences Holdings Inc. The current adx is .

BioForce Nanosciences Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Relative Strength Index (RSI) ChartBioForce Nanosciences Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Stochastic Oscillator ChartBioForce Nanosciences Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Commodity Channel Index (CCI) ChartBioForce Nanosciences Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartBioForce Nanosciences Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Williams %R ChartBioForce Nanosciences Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Average True Range (ATR) ChartBioForce Nanosciences Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily On-Balance Volume (OBV) ChartBioForce Nanosciences Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioForce Nanosciences Holdings Inc.

BioForce Nanosciences Holdings Inc Daily Money Flow Index (MFI) ChartBioForce Nanosciences Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioForce Nanosciences Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-07-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

BioForce Nanosciences Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioForce Nanosciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.050
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of BioForce Nanosciences Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on BioForce Nanosciences Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioForce Nanosciences Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioForce Nanosciences Holdings Inc

I send you an email if I find something interesting about BioForce Nanosciences Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioForce Nanosciences Holdings Inc.

Receive notifications about BioForce Nanosciences Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.